LU79320A1 - Procede de preparation de peptides exercant une activite biologique - Google Patents

Procede de preparation de peptides exercant une activite biologique

Info

Publication number
LU79320A1
LU79320A1 LU79320A LU79320A LU79320A1 LU 79320 A1 LU79320 A1 LU 79320A1 LU 79320 A LU79320 A LU 79320A LU 79320 A LU79320 A LU 79320A LU 79320 A1 LU79320 A1 LU 79320A1
Authority
LU
Luxembourg
Prior art keywords
exercising
biological activity
preparing peptides
peptides
preparing
Prior art date
Application number
LU79320A
Other languages
English (en)
Inventor
W Vale
M Brown
J Rivier
Original Assignee
Salk Inst For Biological Studi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Inst For Biological Studi filed Critical Salk Inst For Biological Studi
Publication of LU79320A1 publication Critical patent/LU79320A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues
LU79320A 1977-03-28 1978-03-28 Procede de preparation de peptides exercant une activite biologique LU79320A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/781,580 US4105603A (en) 1977-03-28 1977-03-28 Peptides which effect release of hormones

Publications (1)

Publication Number Publication Date
LU79320A1 true LU79320A1 (fr) 1978-06-29

Family

ID=25123228

Family Applications (1)

Application Number Title Priority Date Filing Date
LU79320A LU79320A1 (fr) 1977-03-28 1978-03-28 Procede de preparation de peptides exercant une activite biologique

Country Status (19)

Country Link
US (1) US4105603A (fr)
JP (1) JPS53130687A (fr)
AT (1) AT366026B (fr)
AU (1) AU519122B2 (fr)
BE (1) BE865380A (fr)
CA (1) CA1102314A (fr)
CH (1) CH639361A5 (fr)
DE (1) DE2813327A1 (fr)
DK (1) DK131878A (fr)
ES (1) ES468241A1 (fr)
FI (1) FI780907A (fr)
FR (1) FR2385688A1 (fr)
GB (1) GB1564191A (fr)
IE (1) IE46862B1 (fr)
IT (1) IT1105152B (fr)
LU (1) LU79320A1 (fr)
NL (1) NL7803289A (fr)
SE (1) SE446190B (fr)
ZA (1) ZA781599B (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211693A (en) * 1977-09-20 1980-07-08 The Salk Institute For Biological Studies Peptides with para-substituted phenylalanine
US4185010A (en) * 1978-12-12 1980-01-22 American Home Products Corporation Nonapeptides
US4225472A (en) * 1979-05-29 1980-09-30 American Home Products Corporation Truncated somatostatin analogs
USRE30548E (en) * 1979-08-31 1981-03-17 The Salk Institute For Biological Studies Peptides which effect release of hormones
DE19375086I2 (de) * 1979-11-27 2003-01-09 Novartis Ag Polypeptide Verfahren zu ihrer Herstellung pharmazeutische Zusammensetzungen die diese Polypeptide enthalten und ihre Verwendung
FR2523125A1 (fr) * 1982-03-08 1983-09-16 Sanofi Sa Analogues de la somatostatine a activite biologique modifiee et medicaments en contenant
US4428942A (en) 1982-05-17 1984-01-31 The Salk Institute For Biological Studies Analogs of somatostatin
US4443368A (en) * 1982-11-01 1984-04-17 The Salk Institute For Biological Studies Peptides affecting gonadal function
US4880778A (en) * 1986-05-12 1989-11-14 Eastman Kodak Company Combinations having synergistic growth hormone releasing activity and methods for use thereof
US4839344A (en) * 1987-06-12 1989-06-13 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
US4880777A (en) * 1987-09-01 1989-11-14 Eastman Kodak Company Synthetic peptides having growth hormone releasing activity
WO1989007110A1 (fr) * 1988-01-28 1989-08-10 Eastman Kodak Company Composes polypeptidiques ayant une activite de liberation d'une hormone de croissance
US6737408B1 (en) 1997-08-07 2004-05-18 University Of Cincinnati Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm
ATE279437T1 (de) * 1999-08-06 2004-10-15 Genentech Inc Peptidantagonisten des faktors viia
ATE422369T1 (de) * 1999-12-24 2009-02-15 Genentech Inc Verfahren und zusammensetzungen zur verlängerung der entsorgungshalbwertszeit von biowirksamen verbindungen
EP1757311B1 (fr) 1999-12-24 2009-02-11 Genentech, Inc. Méthodes et compositions pour la prolongation de la demi-période d'élimination de composés bioactifs
US20040001827A1 (en) * 2002-06-28 2004-01-01 Dennis Mark S. Serum albumin binding peptides for tumor targeting
US20050287153A1 (en) * 2002-06-28 2005-12-29 Genentech, Inc. Serum albumin binding peptides for tumor targeting
US20060228364A1 (en) * 1999-12-24 2006-10-12 Genentech, Inc. Serum albumin binding peptides for tumor targeting
US7164002B2 (en) 2002-02-06 2007-01-16 Genentech, Inc. FVIIa antagonists
WO2005028498A2 (fr) * 2003-09-18 2005-03-31 Raven Biotechnologies, Inc. Kid3 et anticorps de liaison a kid3
JP4390568B2 (ja) * 2004-01-19 2009-12-24 富士通株式会社 遅延測定システム
US7572895B2 (en) * 2004-06-07 2009-08-11 Raven Biotechnologies, Inc. Transferrin receptor antibodies
AU2005294723A1 (en) * 2004-10-05 2006-04-20 Genentech, Inc. Therapeutic agents with decreased toxicity
WO2006076584A2 (fr) 2005-01-12 2006-07-20 Raven Biotechnologies, Inc. Antigène kid31 (carboxypeptidase m) et anticorps de liaison à celui-ci
JP2008538173A (ja) * 2005-01-31 2008-10-16 レイベン バイオテクノロジーズ，インコーポレイティド Ｌｕｃａ２およびそれに結合する抗体
US20060171952A1 (en) * 2005-02-02 2006-08-03 Mather Jennie P JAM-3 and antibodies that bind thereto
EP1841794B1 (fr) * 2005-02-02 2013-11-20 MacroGenics West, Inc. Modulateurs adam-9
AU2006210606B2 (en) 2005-02-03 2012-03-22 Macrogenics West, Inc. Antibodies to Oncostatin M receptor
US20070197445A1 (en) 2006-01-18 2007-08-23 University Of Cincinnati Compounds for control of appetite
CA2668800A1 (fr) 2006-11-08 2008-06-05 Macrogenics West, Inc. Tes7, et anticorps se liant a celui-ci
WO2010123945A2 (fr) 2009-04-20 2010-10-28 Allergan, Inc. Hydrogels à base de fibroïnes de soie et leurs utilisations
PL219569B1 (pl) 2010-02-19 2015-05-29 Peptaderm Spółka Z Ograniczoną Odpowiedzialnością Cykliczne tetrapeptydy i ich zastosowanie
PL2542256T3 (pl) 2010-03-04 2020-01-31 Macrogenics, Inc. Przeciwciała reaktywne wobec b7-h3, ich immunologicznie czynne fragmenty i ich zastosowania
US8802091B2 (en) 2010-03-04 2014-08-12 Macrogenics, Inc. Antibodies reactive with B7-H3 and uses thereof
EA033677B1 (ru) 2011-05-21 2019-11-15 Macrogenics Inc Cd3-связывающие молекулы, способные к связыванию с cd3 человека и cd3, не являющимся человеческим
HUE031511T2 (en) 2011-08-23 2017-07-28 Harvard College Peptide nanoparticles and their applications
US9487587B2 (en) 2013-03-05 2016-11-08 Macrogenics, Inc. Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
US9908938B2 (en) 2013-03-14 2018-03-06 Macrogenics, Inc. Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof
WO2014154891A1 (fr) 2013-03-29 2014-10-02 Centre National De La Recherche Scientifique (Cnrs) Agoniste de récepteur cgrp pour le traitement ou la prévention du vih
CN106573050B (zh) 2014-05-29 2021-09-24 宏观基因有限公司 特异性结合多种癌症抗原的三特异性结合分子和其使用方法
JP6932639B2 (ja) 2014-09-29 2021-09-08 デューク ユニバーシティ Ｈｉｖ‐１エンベロープ標的化アームを備える二重特異性分子
SG11201706024YA (en) 2015-01-26 2017-08-30 Macrogenics Inc Multivalent molecules comprising dr5-binding domains
TWI773646B (zh) 2015-06-08 2022-08-11 美商宏觀基因股份有限公司 結合lag-3的分子和其使用方法
EA201890296A1 (ru) 2015-07-30 2018-08-31 Макродженикс, Инк. Pd-1-связывающие молекулы и способы их применения
RU2731202C2 (ru) 2015-10-08 2020-08-31 Макродженикс, Инк. Комбинированная терапия для лечения рака
EP3383908A1 (fr) 2015-12-02 2018-10-10 Stsciences, Inc. Anticorps spécifiques au btla glycosylé (atténuateur de lymphocytes b et t)
GEP20217328B (en) 2015-12-14 2021-12-10 Macrogenics Inc Bispecific molecules having immunoreactivity with pd-1 and ctla-4, and methods of use thereof
BR112018071105A2 (pt) 2016-04-15 2019-02-26 Macrogenics, Inc. conjugado de droga e anticorpo, molécula de ligação, composição farmacêutica e uso
US10111929B1 (en) 2017-04-07 2018-10-30 Ez Ip, Llc Growth hormone releasing factor analogs and uses
CN114729045A (zh) 2019-09-26 2022-07-08 斯特库比公司 对糖基化的ctla-4特异性的抗体及其使用方法
US20220356248A1 (en) 2019-10-09 2022-11-10 Stcube & Co Antibodies specific to glycosylated lag3 and methods of use thereof
US11596665B2 (en) 2020-06-23 2023-03-07 Chanda Zaveri Skin lightening formulations
US11951203B2 (en) 2020-08-26 2024-04-09 Chanda Zaveri Deep wrinkle vanishing compositions
US11793746B2 (en) 2020-10-01 2023-10-24 Chanda Zaveri Intense skin hydration systems and methods
US20220110852A1 (en) 2020-10-14 2022-04-14 Chanda Zaveri Pigment Stabilizers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904594A (en) * 1973-07-02 1975-09-09 Salk Inst For Biological Studi Somatostatin and acylated des-(ala' 1', gly' 2') derivatives thereof
US3842067A (en) * 1973-07-27 1974-10-15 American Home Prod Synthesis of(des-asn5)-srif and intermediates
US3917578A (en) * 1973-12-10 1975-11-04 Ayerst Mckenna & Harrison Process for producing somatostatin and intermediates
US3882098A (en) * 1974-01-03 1975-05-06 American Home Prod Synthesis of des-Ala{hu 1{b , Gly{hu 2{b , Asn{hu 5{b -SRIF and intermediates
US4011207A (en) * 1974-12-27 1977-03-08 American Home Products Corporation Des-(Ala1, Gly2,Lys4 -Srif, Des-(Ala1, Gly2, Lys4)-D-Trp8 -Srif and intermediates
US3933784A (en) * 1975-01-27 1976-01-20 American Home Products Corporation Des-(ser13)-srif and intermediates

Also Published As

Publication number Publication date
AU519122B2 (en) 1981-11-12
CH639361A5 (de) 1983-11-15
FR2385688B1 (fr) 1983-10-07
FI780907A (fi) 1978-09-29
JPS6141920B2 (fr) 1986-09-18
BE865380A (fr) 1978-07-17
CA1102314A (fr) 1981-06-02
ZA781599B (en) 1979-10-31
IE46862B1 (en) 1983-10-19
US4105603A (en) 1978-08-08
GB1564191A (en) 1980-04-02
AU3430778A (en) 1979-09-27
IT7848586A0 (it) 1978-03-23
IE780511L (en) 1978-09-28
IT1105152B (it) 1985-10-28
DE2813327C2 (fr) 1988-08-18
SE7803318L (sv) 1978-09-29
DK131878A (da) 1978-09-29
NL7803289A (nl) 1978-10-02
ATA213878A (de) 1981-07-15
SE446190B (sv) 1986-08-18
JPS53130687A (en) 1978-11-14
ES468241A1 (es) 1978-12-01
DE2813327A1 (de) 1978-10-05
FR2385688A1 (fr) 1978-10-27
AT366026B (de) 1982-03-10

Similar Documents

Publication Publication Date Title
LU79320A1 (fr) Procede de preparation de peptides exercant une activite biologique
LU80084A1 (fr) Procede de preparation d'oligoimides
BE869500A (fr) Procede de preparation de l'ethylene
PT64907A (fr) Procede de preparation d'une formulation a activite retarde
BE848601A (fr) Combinaisons a activite biologique, leur procede de preparation
BE865808A (fr) Procede de preparation de l'ethylene-glycol
BE865661A (fr) Procede de preparation de 3-alkyl-butene-1-als
BE862463A (fr) Procede de preparation de 2,5-dichlorophenol
BE865201A (fr) Procede de preparation de 1-amino-3-aryloxy-2-propanols
BE864265A (fr) Procede de preparation d'acides alcoyl-carboxyliques superieurs
LU79019A1 (fr) Procede de preparation d'une composition pesticide a activite synergique
BE870162A (fr) Procede de preparation de p-benzoquinonediacetals
LU80272A1 (fr) Procede de preparation d'agents therapeutiques antiallergiques
BE852577A (fr) Procede de preparation d'un plancher double
BE865532A (fr) Procede de preparation de 2,2-dimethylolalcanals
BE865728A (fr) Procede de preparation du 2,3-dimethylpentanal
LU79074A1 (fr) Procede de preparation de benzyloxime ethers a activite pesticide
LU79540A1 (fr) Procede de preparation d'agents antibacteriens
PT68138A (fr) Procede de preparation de methoxy-2 benzamides
BE837303A (fr) Procede de preparation d'un produit a activite biologique
FR2322609A1 (fr) Composition presentant une activite biologique et son procede de preparation
BE865771A (fr) Procede de preparation d'une zeolite du type a finiment divisee
BE872383A (fr) Procede de preparation de phenylbutenones
BE866923A (fr) Procede de preparation d'alkphosphines
LU79370A1 (fr) Procede de preparation d'acides furoyl-ou thenoylnaphtyloxyalkylcarboxyliques